University Of Zurich
Clinical trials sponsored by University Of Zurich, explained in plain language.
-
Lab test could match brain tumor patients to best drugs
Disease control Not yet recruitingThis study tests a method called pharmacoscopy, where a patient's tumor tissue is analyzed in the lab to find which drugs might work best for them. The goal is to see if this personalized approach is feasible for people with brain tumors that have not responded to standard treatm…
Phase: PHASE2 • Sponsor: University of Zurich • Aim: Disease control
Last updated Jun 23, 2026 11:57 UTC
-
Poop pills for heart health? new study tests gut bacteria transplant in diabetes patients
Disease control Not yet recruitingThis pilot study tests whether transferring gut bacteria from a healthy donor (fecal microbiota transplant) can change the gut microbiome of 30 people with type 2 diabetes and stable coronary artery disease. Participants receive the transplant via colonoscopy and are monitored fo…
Phase: NA • Sponsor: University of Zurich • Aim: Disease control
Last updated Jun 22, 2026 12:08 UTC
-
Weekly adaptive radiation aims to sharply target High-Risk prostate cancer
Disease control Not yet recruitingThis study tests a weekly, image-guided radiation therapy (SBRT) for men with very high-risk prostate cancer that may have spread to nearby lymph nodes. The treatment uses weekly CT or MRI scans to adapt the radiation dose precisely to the tumor. The main goals are to see if this…
Phase: NA • Sponsor: University of Zurich • Aim: Disease control
Last updated Jun 22, 2026 11:57 UTC
-
Could an antidepressant help fight brain cancer? new trial aims to find out.
Disease control Not yet recruitingThis phase II trial tests whether vortioxetine, a drug currently used for depression, can help people with newly diagnosed glioblastoma. The study will enroll 78 adults and measure if the drug extends the time before the cancer worsens. Vortioxetine was selected because lab tests…
Phase: PHASE2 • Sponsor: University of Zurich • Aim: Disease control
Last updated May 26, 2026 12:12 UTC
-
New MRI dye could spot brain tumors sooner in cancer patients
Diagnosis Not yet recruitingThis study tests whether a new MRI contrast agent, gadopiclenol, can detect brain metastases earlier than standard methods in 180 patients with advanced lung, breast, or skin cancer. Participants will receive screening brain MRIs to compare diagnosis timing and accuracy. The goal…
Phase: PHASE2 • Sponsor: University of Zurich • Aim: Diagnosis
Last updated Jun 22, 2026 12:07 UTC
-
New SuperCable aims to speed breastbone healing after heart surgery
Symptom relief Not yet recruitingThis study tests if a new flexible cable (SuperCable) is better than standard steel wire for closing the breastbone after heart surgery. About 86 adults will be randomly assigned to one method. The goal is to see if SuperCable leads to faster bone healing, less pain, and shorter …
Phase: NA • Sponsor: University of Zurich • Aim: Symptom relief
Last updated Jun 18, 2026 11:53 UTC
-
New MRI method aims to sharpen prostate cancer treatment for patients with hip replacements
Symptom relief Not yet recruitingThis study looks at whether a special low-field MRI scanner can give clearer images for prostate cancer radiation therapy in people who have both hips replaced. Standard MRI often creates blurry images around metal implants, making it hard to aim the radiation precisely. The rese…
Phase: NA • Sponsor: University of Zurich • Aim: Symptom relief
Last updated Jun 18, 2026 11:48 UTC
-
Can a breath of fresh air boost brain power? High-Altitude oxygen trial launches
Knowledge-focused Not yet recruitingThis study looks at whether breathing extra oxygen can improve mental performance in healthy people who live at around 2500 meters elevation. Fifty Kyrgyz adults will receive either real oxygen or a sham treatment through a nasal tube, then take tests of reaction time, attention,…
Phase: PHASE4 • Sponsor: University of Zurich • Aim: Knowledge-focused
Last updated Jun 23, 2026 12:00 UTC
-
Scientists dive deep into heart Failure's molecular secrets
Knowledge-focused Not yet recruitingThis study aims to better understand heart failure by combining detailed patient information with advanced molecular analysis. Researchers will study blood samples from 500 adults with heart failure to find specific molecules, called non-coding RNAs, that may be linked to the dis…
Sponsor: University of Zurich • Aim: Knowledge-focused
Last updated Jun 18, 2026 11:51 UTC
-
Study explores why kidneys handle phosphate differently as we age
Knowledge-focused Not yet recruitingThis study looks at how well the body handles phosphate from food as people age and whether men and women respond differently. Researchers will give a phosphate drink to 40 healthy volunteers (young adults aged 18-25 and older adults aged 63-70) and measure phosphate levels in th…
Phase: NA • Sponsor: University of Zurich • Aim: Knowledge-focused
Last updated Jun 18, 2026 11:46 UTC
-
New pain check method aims to cut opioid overuse in ICU
Knowledge-focused Not yet recruitingThis study looks at a new way to assess pain in intensive care patients who are on breathing machines and cannot speak. It uses a special tool (AlgiScan) and a behavioral checklist to adjust pain medicine more safely. Researchers will compare data from 400 adults to see if the ne…
Sponsor: University of Zurich • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:54 UTC
-
Free STD tests for youth: will they like it?
Knowledge-focused Not yet recruitingThis study will ask 1800 young people and people with low incomes in Lucerne and Zurich how satisfied they are with free HIV and STI testing and counseling. The goal is to see if these free services work well and are easy to access. Participants just fill out a questionnaire afte…
Sponsor: University of Zurich • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:03 UTC
-
Scientists to test if processing makes soy safer for allergy sufferers
Knowledge-focused Not yet recruitingThis study looks at how different ways of processing soy (like heating or fermenting) change its ability to cause allergic reactions. Researchers will test processed soy in the lab and then on the skin of 55 adults with soy allergy. The goal is to understand which processing meth…
Phase: NA • Sponsor: University of Zurich • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:05 UTC